Other intracellular red blood cell proteins

The term Other intracellular red blood cell proteins refers to a broad and heterogeneous collection of proteins found within the cytoplasm of erythrocytes, excluding primary proteins like hemoglobin or carbonic anhydrase. This group encompasses a wide range of functional molecules, including glycolytic enzymes such as pyruvate kinase, pentose phosphate pathway enzymes like glucose-6-phosphate dehydrogenase (G6PD), and antioxidant defense proteins like catalase and glutathione peroxidase (D'Alessandro et al., 2017, PubMed). In a pharmacological context, this designation is often used in databases like ChEMBL to describe drugs that partition into or bind non-specifically to the internal components of red blood cells when a specific molecular target has not been isolated. While these proteins are essential for maintaining erythrocyte integrity and metabolic function, they are rarely the primary intended therapeutic target; instead, interactions here are frequently associated with drug sequestration or off-target toxicities such as drug-induced hemolytic anemia (Goodman & Gilman, 12th Ed.). Understanding these interactions is crucial for evaluating the pharmacokinetics and safety profiles of systemic medications, particularly those used in treating hematologic or infectious diseases like malaria where the red blood cell environment is central to the pathology.

Other names

Erythrocyte intracellular proteinsRed blood cell cytosolic proteinsRBC intracellular proteinsNon-specific erythrocyte proteins

Non-specific binding, intracellular sequestration, or modulation of erythrocyte metabolic and redox enzymes.